Exscientia Business and Financial Update for the Full Year 2023 [Yahoo! Finance]
Exscientia Plc - American Depositary Shares (EXAI)
Company Research
Source: Yahoo! Finance
Recent advancements in the Company's pipeline, collaborations and operations, as well as financial results for the fourth quarter and full year 2023, are summarised below. Exscientia will host a conference call Thursday, March 21 at 12:30 p.m. GMT / 8:30 a.m. EDT. "In 2023, we significantly expanded our technological capabilities with the opening of our automation facility, concentrated our internal research on high value oncology targets and steadily progressed multiple new and existing programmes with our large pharma partners," said Dr. David Hallett, interim Chief Executive Officer and Chief Scientific Officer of Exscientia. "In 2024 we will continue to advance our pipeline programmes through clinical development. This includes GTAEXS617 (‘617), our CDK7 inhibitor currently in a Phase 1/2 clinical trial; LSD1, for which we anticipate initiating a Phase 1 patient study this year; and MALT1, which continues to progress through IND-enabling studies. In addition, we look forward to
Show less
Read more
Impact Snapshot
Event Time:
EXAI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EXAI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EXAI alerts
High impacting Exscientia Plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
EXAI
News
- Pomerantz Law Firm Announces the Filing of a Class Action Against Exscientia p.l.c. and Certain Officers - EXAIAccesswire
- The Galien Foundation Announces 2024 Prix Galien International Awards NomineesPR Newswire
- Exscientia plc (NASDAQ: EXAI) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $7.00 price target on the stock.MarketBeat
- The Race Between Biotech And Techbio [Forbes]Forbes
- Investigation into Exscientia Underway: Johnson Fistel, LLP Digs into Alleged Securities Law Violations - What Shareholders Need to KnowGlobeNewswire
EXAI
Earnings
- 3/21/24 - Beat
EXAI
Sec Filings
- 4/24/24 - Form 144
- 4/22/24 - Form 6-K
- 4/8/24 - Form 144
- EXAI's page on the SEC website